Clinical Trials Sponsored by Icare USA

Total 8516 results

Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets, Non-fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mesalamine 4 gm/60 mL Rectal Enema

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ribavirin 200 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefadroxil 500 mg Capsules Under Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefprozil 500 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Zaleplon 10mg Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

Healthy

Canada
AnGes USA, Inc.

Completed

Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia

Ischemia | Peripheral Vascular Disease | Arterial Occlusive Disease

United States
Chugai Pharma USA

Completed

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

Atherosclerosis | Coronary Restenosis | Graft Occlusion, Vascular

United States
Chugai Pharma USA

Completed

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

Breast Cancer | Breast Neoplasms | Metastasis

United States
Horizon Therapeutics USA, Inc.

Completed

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Thyroid Eye Disease

United States
Jetema USA Inc.

Not yet recruiting

Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

Glabellar Lines
TruDiagnostic
Blushield USA

Not yet recruiting

Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

Aging | Aging Well
Teva Pharmaceuticals USA

Completed

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

Dyspareunia

United States, El Salvador, Honduras
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

Rosacea
GlaxoSmithKline
IQVIA, USA

Active, not recruiting

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

Chickenpox

Taiwan, Poland, United States, Estonia, Puerto Rico, Mexico
Taro Pharmaceuticals USA

Completed

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Ribomic USA Inc

Completed

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration (TOFU)

Exudative Age-related Macular Degeneration

United States
Taro Pharmaceuticals USA

Completed

An Open-Label Study to Assess Safety

Plaque Psoriasis

United States
Cipla USA Inc.

Completed

Plazomicin Study in ESRD Patients Receiving IHD

End Stage Renal Disease

United States
Senju USA, Inc.

Completed

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUNRISE)

Chalazion

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Pelvital USA, Inc.

Completed

Pelvital Stress Urinary Incontinence Training Device: P-SUIT

Incontinence

United States
Teva Pharmaceuticals USA

Completed

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Medicrea, USA Corp.

Withdrawn

Personalized Spine Study Group Registry

Degenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann
Intercell USA, Inc.

Completed

LT Vaccine Patch Self-Administration Study

Prevention of Travelers' Diarrhea

United States

3

Subscribe